Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $70.00 short put and a strike $65.00 long put offers a potential 7.99% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $70.00 by expiration. The full premium credit of $0.37 would be kept by the premium seller. The risk of $4.63 would be incurred if the stock dropped below the $65.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Last Week's 5 Top-Performing Stocks on the S&P 500
Wed, 27 Nov 2013 18:00:06 GMT
Motley Fool – Last week's top five performers — three of which were biotech stocks — had returns ranging from nearly 8% to more than 20%. What's up (besides their stock prices)?
$50 Million to $9.5 Billion in 11 Years: An Exclusive Interview with James N. Nelson III of Herndon Capital Management
Wed, 27 Nov 2013 17:17:00 GMT
Wall Street Transcript – 67 WALL STREET, New York – November 27, 2013 – The Wall Street Transcript has just published its current Investing Strategies Report. This special feature contains expert industry commentary through in-depth …
Bargain hunting with the ‘Fast Money' traders
Wed, 27 Nov 2013 17:00:00 GMT
CNBC – The “Fast Money” traders go bargain shopping and debate the best reduced stock plays.
Interesting GILD Put And Call Options For January 2014
Wed, 27 Nov 2013 15:55:00 GMT
Forbes – Investors in Gilead Sciences, Inc. (NASD: GILD) saw new options begin trading today, for the January 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD options chain for the new January 2014 contracts and identified one put and one call contract of particular
2014 FDA Drug Approval Decision Calendar
Wed, 27 Nov 2013 13:00:00 GMT
TheStreet – Here's a list of 34 FDA drug approval decisions and scheduled advisory panels from December 31 through October 2014.
Related Posts
Also on Market Tamer…
Follow Us on Facebook